ducovest

XUCS:F:F-Xtrackers (IE) Public Limited Company - Xtrackers MSCI USA Consumer Staples UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 40.005

Change

-0.05 (-0.12)%

Market Cap

USD 0.09B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Currency: EUR

Country : Germany

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

 USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

N/A

 USD 113.22B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

 USD 83.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

 USD 77.76B
FRCJ:F UBS MSCI Japan Socially Respon..

N/A

 USD 73.13B
EUNL:F iShares Core MSCI World UCITS ..

N/A

 USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

 USD 56.29B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

 USD 54.81B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

 USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

 USD 51.63B

ETFs Containing XUCS:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.06% 78% C+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.06% 76% C+ 65% D
Trailing 12 Months  
Capital Gain 4.10% 43% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.10% 41% F 49% F
Trailing 5 Years  
Capital Gain 42.27% 69% C- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 42.27% 68% D+ 56% F
Average Annual (5 Year Horizon)  
Capital Gain 6.50% 71% C- 69% C-
Dividend Return 6.50% 70% C- 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.57% 57% F 80% B-
Risk Adjusted Return 61.49% 87% B+ 88% B+
Market Capitalization 0.09B 25% F 30% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.